DCTH — Delcath Systems Share News
0.000.00%
- $403.56m
- $314.26m
- $85.23m
Brief: Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
Brief: Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer
Delcath Systems Inc reports results for the quarter ended September 30 - Earnings Summary
Delcath Systems Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
Delcath Systems rises as co expects wider-than-estimated Q3 revenue
Brief: Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
Brief: Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Delcath Systems Inc reports results for the quarter ended in June - Earnings Summary
Delcath Systems Inc expected to post a loss of 36 cents a share - Earnings Preview
Delcath Systems Inc reports results for the quarter ended in March - Earnings Summary
Delcath Systems Inc expected to post a loss of 47 cents a share - Earnings Preview
Delcath Systems Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Delcath Systems Files Prospectus Relates To Offer And Resale Of Up To 1.91 Mln Shares
Brief: Delcath Systems Extends Term Of Agreement To December 31, 2028
Brief: Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems Inc reports results for the quarter ended in December - Earnings Summary
Delcath Systems Inc expected to post a loss of 51 cents a share - Earnings Preview